GlassScriptPhysician profile
Aasha S Gopal
NPI 1306809579
$12,160.58
in general payments reported to CMS, 2019-2025
19 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $4,058 · 2023: $568 · 2024: $5,477 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $1,832 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $1,831.99 |
| Travel and Lodging | $1,012.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,206.76 | 2023-2024 | Watchman Access System, Watchman Flx |
| Ge Healthcare | $3,600.00 | 2022 | |
| Abbott Laboratories | $1,155.00 | 2022-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Novartis Pharmaceuticals Corporation | $489.87 | 2022-2025 | |
| Medtronic, INC. | $322.17 | 2022-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.66 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $191.88 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $184.81 | 2023-2025 | Camzyos, Eliquis |
| Amgen INC. | $151.74 | 2021-2023 | Repatha |
| Biosense Webster, INC. | $139.82 | 2025 | Nuvision Ice Catheter |
| Kestra Medical Technology Services, INC. | $125.34 | 2023 | Assure Wcd |
| Pfizer INC. | $119.33 | 2025 | |
| Recor Medical INC | $82.61 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bayer Healthcare Pharmaceuticals INC. | $52.64 | 2025 | |
| Lantheus Medical Imaging, INC. | $52.19 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $29.16 | 2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.65 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $19.81 | 2021 | |
| Chiesi USA, INC. | $18.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aasha Gopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.